Clobetasol Propionate

丙酸氯倍他索

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameClobetasol Propionate
Drug Alias Name丙酸氯倍他松Clobetasolum丙酸氯氟美松氯倍他索丙酸脂Impoyz +[19
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPlaque psoriasisPostoperative inflammationPain, Postoperative +[20
Global Approved IndicationsPsoriasisLichen PlanusPruritus +[8
Approved Indications in ChinaPsoriasisLichen PlanusPruritus +[7
Original Approved Country/TerritoryUnited States
Original Approved Date1985/12/27
Country/TerritoryCanadaUnited StatesSweden +[10
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active IndicationsPsoriasisLichen PlanusPruritus +[9
Inactive IndicationsPlaque psoriasisPostoperative inflammationPain, Postoperative +[11

Other Information

ATC CodeD07AD01